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Abstract
Muscle inactivity reduces muscle protein synthesis (MPS), whereas a subsequent period of rehabilitation resistance training
(retraining) increases MPS. However, less is known regarding muscle protein breakdown (MPB) during such conditions.
Furthermore, nonsteroidal anti-inflammatory drugs (NSAIDs) may have a dampening effect onMPB during periods of inactivity
in older individuals. Thus, wemeasured the averageMPB, by use of the deuterated water methodology, during an immobilization
period and a subsequent retraining period in older individuals with and without NSAID treatment. Eighteen men (60–80 years:
range) were randomly assigned to ibuprofen (1200 mg/d, Ibu) or placebo (Plc). One lower limb was immobilized in a cast for
2 weeks and retrained for 2 weeks, and 2 × 20 g of whey protein was ingested daily during both periods. Besides MPB, the
protein expression of different muscle degradation signaling molecules was investigated. MPB was lower during immobilization
compared to retraining (p < 0.01). NSAID treatment did not affect the MPB rate during immobilization or retraining (p > 0.05).
The protein expression of muscle degradation signaling molecules changed during the study intervention but were unaffected by
NSAID treatment. The finding that MPB was lower during immobilization than during retraining indicates that an increased
MPB may play an important role in the muscle protein remodeling processes taking place within the initial retraining period.
Moreover, NSAID treatment did not significantly influence the MPB rate during 2 weeks of lower limb immobilization or during
2 weeks of subsequent retraining in older individuals.
Keywords Deuteratedwater . Deuterated alanine .Muscle degradation .Muscle disuse .Muscle recovery . NSAID
Introduction
Disuse of skeletal muscle either in the form of reduced use [7],
bed rest [13, 14], or immobilization [11, 41] causes atrophy.
While it is well-established that the muscle protein synthesis rate
declines during immobilization, the role of muscle protein break-
down (MPB) in relation to inactivity-induced muscle atrophy is
less clear. So far, only few attempts have been made to measure
MPB after periods of muscle inactivity. By use of the arteriove-
nous balance model in combination with stable isotope infusion,
it has been demonstrated that theMPB is unchanged after 14 days
of bed rest in young men [14]. Furthermore, through pulse iso-
tope infusions, it has been shown that the muscle fractional
breakdown rate (FBR) is unchanged after 21 days of bed rest
in young men [42]. However, another study reported that inter-
stitial 3-methylhistidine, a biomarker of myofibrillar protein
breakdown, was increased with 3 days of immobilization in
young men [44]. Taken together, these findings indicate that
the MPB may variate throughout the period of muscle inactivity
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with a transient elevation during the early inactivity period
followed by a return to baseline levels during sustained periods
of inactivity. However, the findings obtained with the tracer di-
lution methods provide a nonprotein-specific MPB measure-
ment, and moreover, all reported values represent acute “snap
shots” of the MPB rate. Therefore, these findings may not be
fully representative of the MPB during daily life periods of im-
mobilization. Although the tracer dilutionmethods can be advan-
tageous in relation to measurement of net tissue balance with a
high time resolution, the deuterated water methodology provides
a protein specific and direct measurement of the average MPB
over a period of daily living (days) [18].
Conduction of muscular contractions, e.g., resistance exer-
cises, stimulates muscle protein turnover rates in the following
hours/days of recovery [3, 30]. Moreover, muscle protein syn-
thesis has been shown to be elevated during the first 8 days of
resistance exercise training [50]. However, less is known regard-
ing the specific fluctuations in MPB during prolonged periods
with repeated resistance exercise sessions, although it seems pos-
sible that the MPB would increase due to the processes of skel-
etal muscle remodeling that occurs during the early period of
unaccustomed resistance exercise [9]. Especially, the early period
of rehabilitation resistance training, after a period of muscle in-
activity, could be expected to have a significant impact on the
overall muscle protein turnover and hence also muscle MPB.
Nevertheless, as compared to the state of inactivity, early reha-
bilitation resistance training represents the complete opposite
state, and hence, the two conditions make up two “extremes”
within the normal life span of most people.
It has been demonstrated that NSAIDs may influence the
muscle mass adaptation to periods of resistance training in
healthy, older humans [45], as a consequence of alterations
in muscle protein turnover kinetics [46]. Especially, the obser-
vation that NSAIDs inhibit the training induced increase in
muscle gene expression of interleukin-6 (IL-6) and muscle
RING finger protein 1 (MuRF-1) indicates that MPB may
be affected by NSAID intake [46]. Moreover, supplementa-
tion with dietary omega-3 fatty acids (which can have anti-
inflammatory effects [2, 16]) prior to and during 10 days of
immobilization has been shown to alleviate muscle catabolism
in healthy, adult rats [51]. This muscle-preserving effect was
partly achieved by eliminating the increases in the muscle
expression of the ubiquitin ligases, MuRF1 and Atrophy
gene-1 (Atrogin-1) [51], which regulate muscle degradation
via the ubiquitin-proteasome system [27, 35]. Somehow in
line with that, it has been demonstrated that protein feeding
induces an increase in Forkhead box O (FoxO)-3a phosphor-
ylation, alongside a decrease in muscle degradation, in elderly
inflamed rats treated with NSAID, but not in placebo-treated
rats [33]. Taken together, these findings could indicate that
anti-inflammatory treatments may have a diminishing effect
on MPB in both catabolic and anabolic situations such as
muscle inactivity, protein ingestion, and resistance training.
Even though the effect of NSAID on both muscle gene and
protein signaling response to resistance exercise has been in-
vestigated [25, 46, 48], the information is still sparse. The
nuclear factor-kappa B (NF-κB) transcriptional activator is
regarded as a central regulator of muscle inflammatory signal-
ing pathways that can induce transcription of the atrogens,
which may ultimately lead to increased muscle degradation
[20, 21, 36, 48]. Upon activation of the NF-κB complex, reg-
ulatory molecules, which keep the NF-κB transcription factors
sequestered in the cytosol, are phosphorylated and removed,
which leads to the transport of NF-κB transcription factors
into the nucleus [20, 21, 36, 48]. Therefore, the relationship
between the concentrations of NF-κB transcription factors,
measured in the cytosol and the nucleus subcellular fractions,
respectively, could give an indication of the NF-κB activation.
Interestingly, the observation that NSAIDs may inhibit the
training induced increase in MuRF-1 gene expression [46]
has led to speculations of that this may occur through a path-
way involving both prostaglandin (PG)E2 and NF-κB [38,
46]. However, other work could not clearly demonstrate that
NSAID affected the activation NF-κB [48], and more work is
needed to further clarify this.
The present study aimed to investigate the rate and
intramyocellular regulation (protein signaling) of the MPB
process during 2 weeks of lower limb immobilization and
2 weeks of subsequent retraining. Since immobilization may
induce some degree of local muscle inflammation [40],
NSAID treatment was applied to dampen local muscle inflam-
mation during a period of immobilization and retraining. The
deuterated (2H2O) water–based method was used to assess the
gross average myofibrillar fractional breakdown rate, as pre-
viously described [18]. Furthermore, protein concentrations of
signaling molecules related to MPB were measured both in
the cytosolic and nuclear subcellular fractions at baseline, im-
mediately after immobilization, 20 h after the first retraining
session and after 2 weeks of retraining. We assumed that
prolonged inactivity obtained by immobilization would de-
crease muscle protein turnover rates (also MPB), and there-
fore, it was hypothesized that MPB would be lower compared
to during the subsequent retraining period. Furthermore, it was
hypothesized that treatment with NSAID would have a damp-
ening effect on MPB during immobilization but that it would
not influence the retraining conditions.
Methods
Study design
Experimental protocol
Eighteen healthy, older males (age, 60–80 years; BMI, 20–
30 kg/m2) were recruited through newspaper advertisements.
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The included subjects had no cancer andmetabolic, cardiac, or
neurological diseases; were nonsmokers and recreationally
physically active; and had not taken part in any form of stren-
uous endurance or resistance training before trial participation.
Furthermore, subjects gave their written informed consent be-
fore being enrolled in the experiment that were approved by
the Copenhagen Ethics Committee (H-1-2010-007) and
conformed to the Helsinki Declaration. Finally, subjects were
instructed not to take any kind of analgesic medication at least
2 weeks before the beginning of the study.
The experimental design is shown in Fig. 1. The present
investigation was a part of another experiment that investigat-
ed the effect of ibuprofen treatment on muscle mass and
strength adaptation during 2 weeks of lower limb immobili-
zation and 6 weeks of subsequent retraining [11]. Moreover,
the subject characteristic data of the included individuals have
been used in previous studies [4, 11, 12], whereas all other
presented data have not been reported previously.
Ibuprofen treatment and protein supplementation
The included individuals were divided into 2 groups receiving
either placebo (Plc, n = 10) or ibuprofen (Ibu, n = 8) in a ran-
domized and double-blinded fashion. As previously described
[11], the placebo group consists of 2 groups. The first group of
4 subjects has been included in a previous study [4] and re-
ceived double-blinded placebo injections (placebo or growth
hormone), whereas the remaining 6 subjects in the placebo
group received placebo tablets in a double-blinded fashion
(placebo or ibuprofen). All subjects completed the study in-
tervention during the same time period.
The ibuprofen treatment started 2 days before the immobi-
lization period to ensure that all subjects were fully treated
from the onset of immobilization. The placebo tablets
contained mainly potato starch and lactose monohydrate and
were visually identical to the ibuprofen tablets. Moreover, all
individuals were instructed to take their daily tablets (2 ×
600 mg/day) at the same time every morning and evening
together with a meal and to return the empty packages.
Furthermore, subjects were not allowed to consume any
cyclooxygenase-inhibiting drugs besides the tables provided
during the study period.
The present study was carried out under free-living condi-
tions, and all subjects were instructed to maintain their normal
diets and to consume 2 × 20 g of whey protein (Lacprodan,
Arla Foods Ingredients P/S, Viby J, Denmark) each day
throughout the study period, as previously described [11].
This was done to ensure that eventual differences in myofi-
brillar FBR between groups would not be due to insufficient
intake of protein and essential amino acids in one of the
groups. Finally, both the ibuprofen treatment and the protein
supplementation were initiated at baseline (day 70) and main-
tained for the rest of the study period.
Unilateral limb immobilization and retraining
The immobilization procedure has previously been described in
detail and shown to induce substantial quadricepsmuscle atrophy
in both young and older individuals [4, 5]. Briefly, immobiliza-
tion was accomplished by a lightweight fiber cast applied from
the groin to just proximal to the malleoli (randomly selected
limb). The cast was positioned at 50° of knee joint flexion to
impede walking ability (0° corresponding to full extension).
Furthermore, the subjects were carefully instructed to avoid any
kind of quadriceps muscle contractions and to use crutches for
locomotion. However, subjects were encouraged to remain phys-
ically active during the unilateral immobilization period, al-
though it may cause them some difficulties. Moreover, all
Fig. 1 Study intervention protocol. 18 older men completed 2 weeks of
immobilization (2-week IM) and 2 weeks of retraining (2-week retrain)
during which period they all ingested 2 × 20 g of whey protein per day.
The participants were randomized into groups double blindly receiving
either ibuprofen (n = 8) or placebo (n = 10) administration (2 × 600 mg/
day). Measurements were performed at baseline, after 2-week IM, after
the first retraining session (20-h retrain), and after 2 weeks of retraining
(2-week retrain)
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subjectswere treatedwith acetylsalicylic acid (75mg/day) during
the 2-week immobilization period to reduce the potential risk of
deep venous thrombosis. Even though acetylsalicylic acid is an
NSAID, the anti-inflammatory effect of such a low dose was
most likely negligible.
After removal of the cast, the subjects received supervised
unilateral resistance training 3 times per week for 2 weeks (all
individuals completed a total of 6 weeks of retraining, but only
the 2 first weeks are included in the present investigation).
After 5 min of warm-up on a stationary bike, the subjects
performed knee extension and leg press in randomized order
in training machines (Technogym, Gambettola, Italy). The
training intensity and volume were 3–4 sets × 12 repetitions
(15 repetitions maximum (RM)) in week 1 and 4 sets × 10
repetitions (12 RM) in week 2. The training load was adjusted
each week by the use of 5 RM tests.
Measurements
At inclusion, the whole-body lean body mass (LBM) was
determined by dual-energy X-ray absorptiometry scanning
(Lunar DPX-IQ, GE Healthcare, Chalfont St. Giles, UK).
During the scan, the individuals were wearing light clothing,
no removable metal objects, and placed in a supine position.
Thereafter (at day 0), subjects drank a total volume of
5.25-mL/kg LBM−1 of 99% 2H2O, which was diluted 1:1 with
tap water and provided in 2–3 boluses over a 1-h period.
Venous blood samples were taken right before and 2 h after
the deuterated water bolus was consumed, and again at base-
line (day 70), after immobilization (day 86), and after 2 weeks
of retraining (day 100) in order to determine the deuterium
enrichment of serum-free alanine. Blood samples were drawn
from the antecubital vein into clot activator tubes, which were
allowed to clot at room temperature for 30 min and followed
by centrifugation (10min at 3970 g at 4 °C). Serumwas stored
(− 80 °C) for analyses of 2H-alanine enrichment.
At baseline, after immobilization, and after 2 weeks of
retraining, the subjects met at the lab, were placed in a supine
position, and had a muscle biopsy taken from the vastus
lateralis muscle using local anesthesia (lidocaine, 1%) and a
5-mm Bergström needle with suction. The muscle biopsies
were cleared of external adipose tissue, connective tissue,
and blood; frozen in liquid nitrogen; and stored at − 80 °C
for subsequent analysis. The muscle biopsies were taken from
the non-immobilized limb at baseline and from the
immobilized limb after immobilization and 2 weeks of
retraining. The biopsies from the immobilized limb were
placed at least 3 cm apart to obtain samples unaffected by
previous biopsies, and the order of location was randomized.
Furthermore, these three biopsies were used for measurement
of both muscle protein-bound abundances of 2H-alanine and
muscle degradation signaling. The individuals refrained from
strenuous physical activity 72 h prior to biopsy sampling at
baseline (day 70), whereas prior retraining sessions were per-
formed approximately 48 h before the biopsy obtained after
2 weeks of retraining (day 100). Additionally, a muscle biopsy
was taken from the immobilized limb 20 h after the first
retraining session (at day 87), with the purpose to measure
the muscle degradation signaling response to acute retraining.
At baseline and after immobilization, the biopsies were taken
in the fasted state, whereas a light meal was ingested in the
morning of the day of biopsy sampling after the first retraining
session and after 2 weeks of retraining (ingested 2–3 h before
the biopsy sampling). Finally, all muscle biopsies were col-
lected at the same time of the day (± 1 h) to avoid effects of
circadian variations on muscle degradation signaling.
Analyses
Serum-free alanine preparation
Serum 2H-alanine enrichment was measured in 200-μL serum.
The samples were acidified with 1-mL 50% acidic acid and
poured over resin columns (AG 50 W- × 8 resin; Bio-Rad
Laboratories, Hercules, CA) preconditioned with 1-mL 50%
acidic acid. After 5 washes with Millipore water, the purified
amino acids were eluted with 2 × 1 mL of 2-M NH4OH. After
being dried down under a stream of nitrogen, the purified amino
acids were derivatized using MtBSTFA + 1% tBDMCS (Regis
Technologies, Inc., Morton Grove, IL, USA) and acetonitrile
with a volume relation of 1:1. The tBDMS derivatives of the
amino acids were separated by gas chromatography (GC) on a
30-m CP-Sil 8 CB capillary column (ChromPack, Varian, Palo
Alto, CA) using programmed temperature vaporization (PTV)
mode and injecting approximately 1 μL. The alanine deriva-
tives were analyzed by tandemmass spectrometry (MS) using a
Thermo Scientific, TSQ Quantum GC-MS/MS (San Jose, CA,
USA), operating in the electron ionization mode, as previously
described [19].
Muscle myofibrillar protein-bound alanine preparation
Muscle specimens of 10–20-mg wet weight were homoge-
nized (Fast-prep, 120A-230; Thermo Savant, Holbrook, NY,
USA) for 2 × 45 s in 1.5 ml of ice cold Milli-Q saline water.
After a spin (5 °C, 5.500 g, 10 min), the pellet was added 1 ml
of homogenization buffer (0.02 M Tris, pH 7.4, 0.15 M NaCl,
2 mM EDTA, 0.5% Triton-X 100, and 0.25 M sucrose), ho-
mogenized for 2 × 45 s (Fast-prep), and left for 3 h at 5 °C.
After a spin (5 °C, 800 g, 20 min), 1 ml of a homogenization
buffer (0.02 M Tris, pH 7.4, 0.15-M NaCl, 2-mM EDTA,
0.5% Triton-X 100, and 0.25-M sucrose), homogenized for
45 s, and left for 30 min at 5 °C. After a spin (5 °C, 800 g,
20 min), the pellet was added 1.5 ml of high-salt solution (0.7-
M KCl, 0.1-M pyrophosphate), homogenized (vortexed), and
left overnight at 5 °C. After vortex and spinning (5 °C, 1600 g,
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20 min), the supernatant (containing the myofibrillar fraction)
was added 3.45-ml ethanol (99%), vortexed, and left for 2 h at
5 °C. After spinning (5 °C, 1600 g, 20 min), 1 ml of 70%
ethanol was added to the pellet, which was vortexed and spun
(5 °C, 1600 g, 20 min), where after the pellet was hydrolyzed
overnight in 1 ml of 6 M HCl at 110 °C. The liberated amino
acids were purified over resin columns (as described above for
serum-free alanine) and N-acetyl-n-propyl (NAP)-derivatized.
The 2H abundance in human myofibrillar proteins was ana-
lyzed on a gas chromatograph-pyrolysis-isotope ratio mass
spectrometer (GC-P-IRMS) system (GC Combustion III,
Delta Plus XL; Thermo Finnigan, Bremen, Germany). As
previously described [18], the NAP-derivatized samples were
injected in the PTV mode with the GC inlet initially set at
45 °C for 1 min, where after it was elevated to 280 °C with
20 °C/min. The GC column (30 m × 0.25-mm film thickness,
1 μm DB-1701; J&W Scientific) was ramped from 45 to
280 °C, and all GC column effluent passed into a high-
temperature reduction reactor (1450 °C), where the organic
compounds were reduced to hydrogen gas and carbon mon-
oxide before entering the IRMS.
Calculation of muscle myofibrillar protein FBR
Paired samples were obtained, and we were able to determine
the FBR of each individual’s muscle myofibrillar protein frac-
tion. By log transformation of the measured enrichment
values, the slope, kB, of the ln(E) versus time curve was de-
termined as a gross mean between adjacent biopsy time points
(16 days for immobilization and subsequently 14 days of
retraining) [18].
Western blot analyses
Muscle samples of 10–25mgwere homogenized using a plas-
tic pestle and fractionated into a cytosolic and nuclear fraction
using a commercial fractionation kit (ProteoExtract
Subcellular Proteome Extraction Kit, 539,790, Merck,
Darmstadt, Germany) according to the manufacturer’s proce-
dures. Subsequently, protein concentrations on the cytosolic
and nuclear fractions were quantified using a commercial mi-
croplate kit (Bio-Rad DC protein microplate assay, 0113,
0114, 0115, Bio-Rad Laboratories, Hercules, CA, USA).
Equal amounts of protein were loaded per well (20–30 μg)
and separated by 4–20% gradient Mini-PROTEAN TGX
Stain-Free Precast protein gels (4,568,093, Bio-Rad
Laboratories). Electrophoresis was performed under
denaturized conditions for 40–45 min at 200 V in cold
Tris/Glycine/SDS running buffer (161–0732, Bio-Rad
Laboratories). After gel electrophoresis, proteins were trans-
ferred onto a PVDF-membrane at 100 V for 30 min
(CriterionTM Blotter; Tris/Glycine buffer 161–0734, Bio-Rad
Laboratories). Membranes were blocked at room temperature
for 2 h in a TBS solution with 5% fat-free skimmed milk and
0.1% Tween 20 (TBS, 170–6435, Bio-Rad Laboratories;
Tween-20, 437082Q, VWR International, Radnor, PA, USA;
Skim milk, 1.15363.0500, Merck). Blocked membranes were
incubated overnight at 4 °C with a primary antibody against
ubiquitin (3933, Cell Signaling Technology, Danvers, MA,
USA) diluted 1:1000. After incubation, membranes were
washed and incubated at room temperature for 1 h with a
secondary antibody diluted 1:3000 (7074, Cell Signaling
Technology). After detection, membranes were stripped of
primary and secondary antibodies using Restore Western
Blot Stripping Buffer (21,059, Thermo Fisher Scientific,
Rockford, IL, USA), blocked for 2 h at room temperature,
and incubated at 4 °C overnight with antibodies against
FoxO3a (2497, Cell Signaling Technology), NF-κB p65
(ab7970, Abcam, Cambridge, UK), and IκBα (ab32518,
Abcam), diluted 1:1000, 1:500, and 1:400, respectively.
Subsequently, membranes were incubated in secondary anti-
body (7074, Cell Signaling Technology). All antibodies were
diluted in a 1% fat-free skimmed milk TBS solution added
0.1% Tween-20. Between stages, membranes were washed in
0.1% TBS-T. All samples were analyzed in duplicates, and
bands were visualized using a HRP-detection system (Super
Signal West Dura Extended Duration Substrate, 34,076,
Thermo Fisher Scientific). Chemiluminescence was measured
using a ChemiDoc MP System (Bio-Rad Laboratories), and
band intensities were calculated with Image Lab (Bio-Rad
Laboratories). The use of stain-free technology allowed nor-
malization to tryptophan content in the membranes after trans-
fer, as these gels have been added a 58-Da Trihalo compound
that covalently binds to tryptophan residues in proteins when
expressed to ultraviolet (UV) light.
Statistics
The sample size was calculated based on the hypothesis on the
fractional breakdown rates. We estimated the relative differ-
ence in FBR between the two conditions as the following. In
the immobilized and retraining states, we expected a reduction
and increase of ~20%, respectively, from normal living/
activity conditions. We used a value for normal living/
activity conditions of 1.73 ± 0.49%/d (mean ± SD) [18], and
hence, we estimated the sample size based on a power of 0.80,
a significance level of 0.05, and a group difference of 0.7 ±
0.4%/d to a total of seven research participants in two inde-
pendent groups.
Before statistical analysis, all data set were tested for nor-
mality. Data were analyzed using a two-way ANOVA with
repeated measures and Student–Newman–Keuls post hoc
tests were performed when significant overall effects were
observed. Muscle protein signaling data were log transformed
before the statistical analysis and presented as geometric
means ± back-transformed SE. Data are reported as means ±
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standard error of mean (unless otherwise stated). Differences
were considered significant when p < 0.05. The statistical soft-
ware SigmaPlot v. 12.3 (Systat Software Inc., San Jose, CA,
USA) was used for all statistical tests.
Results
Subject characteristic
Age, height, weight, and body mass index did not differ be-
tween groups. Body weight (kg) was 78 ± 3, 79 ± 3, and 79 ±
3 in the Plc group and 84 ± 3, 84 ± 4, and 84 ± 4 in the Ibu
group at baseline, after immobilization, and after 2 weeks of
retraining, respectively. For body weight, an interaction effect
(p < 0.05) was observed, and the post hoc test indicated that
body weight was higher (p < 0.05) after immobilization and
2 weeks of retraining in the Plc group, whereas it did not
change in the Ibu group.
The subjects completed the immobilization and retraining
periods without reporting any clinical problems. Subjects re-
ported full compliance regarding the ibuprofen administration
and protein intake, which was supported by measurements of
blood ibuprofen concentration indicating that all subjects in
the Ibu group took their medication regularly, as described
previously [11]. Furthermore, the total training load and train-
ing intensity did not differ between the Ibu and the Plc group,
as described previously [11].
Due to insufficient availability of muscle biopsy material,
the myofibrillar FBR was measured in both the immobiliza-
tion and retraining periods in 7 (of 8) and 6 (of 10) individuals
in the Ibu and Plc groups, respectively. Further, at the time
point of 20 h after the first retraining session, muscle degra-
dation signaling could only be obtained in 6 (of 10) subjects in
the Plc group and in 7 (of 8) subjects in the Ibu group. At all
other time points, the muscle MPB signaling was measured in
all the included individuals.
Serum 2H-alanine enrichment
An overall time effect (p < 0.001) was found for the serum-
free 2H-alanine enrichment (Table 1). Two hours after inges-
tion of deuterated water (day 0), a marked 2H-alanine enrich-
ment appeared in both groups (p < 0.001). At day 70 (start of
immobilization period), 86 (end of immobilization), and 100
(end of retraining period), the 2H-alanine abundance had dis-
appeared and was not different from zero (p > 0.05).
Muscle myofibrillar protein-bound 2H-alanine
and fractional breakdown rate
An overall time effect (p < 0.01) was found for myofibrillar
FBR (Fig. 2). The myofibrillar FBR was 1.61 ± 0.14%·d−1
during the immobilization period and 2.12 ± 0.34%·d−1 during
the retraining period, in the Plc group. In the Ibu group, the
myofibrillar protein FBR were 1.33 ± 0.23%·d−1 during the
immobilization period and 2.27 ± 0.17%·d−1during the
retraining period.
Muscle protein breakdown signaling
Muscle protein concentrations of signaling targets related to
MPB are shown in Figs. 3 and 4. The biopsies pre- and post-
immobilization (Fig. 3) were taken during overnight fasting
conditions, whereas a standardized meal was ingested in the
morning before muscle biopsy sampling during retraining
(Fig. 4). Thus, the protein expressions related to immobiliza-
tion and retraining, respectively were analyzed in separate
statistical tests.
Among all the investigated protein targets, no group effects
were found (p > 0.05). An effect of group x time (interaction)
was found for cytosolic ubiquitin expression (p < 0.05), but
subsequent post hoc tests did not reveal any significant differ-
ences (Fig. 4f). However, overall time effects were identified
(p < 0.05), revealing a difference during immobilization and
retraining, respectively. Results from the post hoc tests are
described in the following sections.
FoxO3a concentration
The protein expression of FoxO3a in the cytosolic subcellular
fraction (Fig. 3a) decreased after immobilization. During re-
train, no differences were seen between the first retraining
session and after 2 weeks of retraining (Fig. 4a). The nuclear
FoxO3a protein expression was unchanged after 2 weeks of
immobilization (Fig. 3b) and was not affected by retraining
(Fig. 4b).
NF-κB p65 concentration
The cytosolic NF-κB p65 protein expression was unchanged
after immobilization (Fig. 3c), and not significantly affected
Table 1 Serum 2H-alanine enrichment measured 2 h after ingestion of
deuterated water (day 0), as well as at day 70 (start of immobilization),
day 86 (end of immobilization/start of retraining), and day 100 (end of
retraining)
Serum 2H-alanine enrichment Plc Ibu
Day 0 0.542 ± 0.033* 0.500 ± 0.015*
Day 70 − 0.009 ± 0.007 − 0.008 ± 0.015
Day 86 − 0.026 ± 0.015 0.010 ± 0.013
Day 100 − 0.010 ± 0.005 0.030 ± 0.023
Data were analyzed with a two-way repeated measure ANOVA: A time
effect (p < 0.001) was observed. *Significant different from all other
values (p < 0.001). Data are means ± SE
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during retraining (Fig. 4c), although a tendency toward an
effect of time was seen in the latter condition (p = 0.074).
After immobilization, the nuclear NF-κB p65 expression
was unchanged (Fig. 3d), whereas after the first retraining
session, nuclear NF-κB p65 expression was greater than after
2 weeks of retraining (Fig. 4d).
Cytosolic IκBα and ubiquitinated protein concentrations
The cytosolic IκBα protein expression remained unchanged
throughout the study period (Fig. 3e and Fig. 4e). The cyto-
solic expression of ubiquitinated proteins was unchanged after
immobilization (Fig. 3f). During retraining, an interaction ef-
fect was seen (Fig. 4f, p = 0.042). However, the post hoc tests
could not reveal any significant differences.
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Fig. 3 a, b, c, d, e, and f. Muscle
proteolysis signaling at baseline
and after 2 weeks of
immobilization (2-week IM).
Data are expressed relative to
baseline levels and presented as
geometric means ± back-
transformed SE. Log-transformed
data were analyzed with a two-
way repeated measure ANOVA.
No group or interaction effects
were observed (p > 0.05), but
time effects appeared (p < 0.05). a
Denote significant different from
baseline (p < 0.05). Tendency
(0.05 < p < 0.10) from ANOVA
testing is shown within figure in
upper right panel
Fig. 2 Muscle myofibrillar fractional breakdown rates (FBR) during
2 weeks of immobilization (• Immobilization) and 2 weeks of retraining
(♦ Retraining). Data were analyzed with a two-way repeated measure
ANOVA: A time effect (p < 0.01) was observed. Each dot represents
the FBR of an individual, and connected dots are repeated measures
during immobilization and retraining
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Discussion
The primary finding was that the gross average myofibrillar
breakdown rate was lower during 2 weeks of immobilization
than during 2 weeks of subsequent retraining, whereas
NSAID treatment had no impact on the myofibrillar break-
down rate. Moreover, muscle degradation signaling in the
cytosolic and nuclear subcellular fractions differed between
the measured time points, and correspondingly, the signaling
was unaffected by NSAID treatment.
The present method of measuring muscle protein breakdown
rate allowed us to determine a gross average over a 2-week
period with the subjects staying in their usual living environ-
ments, hence reflecting real-life situations. Previously, the influ-
ence of physical inactivity on MPB has been measured in stan-
dardized laboratory setups [14, 42, 44]. However, to translate
these acute “snap shot”measurements into the long-term changes
taking place during periods of free-living muscle unloading the
momentary measures of protein breakdown rates do not fully
depict how changes in muscle protein breakdown rates under-
lines changes in muscle mass over time. The present method
included both post-prandial and post-absorptive periods as well
as periods of sleep, which makes it more representative of the
actual myofibrillar breakdown rate during a given intervention
and a better exploratory parameter for understanding the mecha-
nisms underlying changes in muscle mass [11]. During the first
2 weeks of immobilization, fluctuations in the breakdown rate
may have occurred [1, 44, 49]. A possible increase inMBP from
the basal level during the initial days of muscle inactivity may
likely have been counterbalanced by a later drop resulting in the
reported average rate over the course of the 2-week measuring
period [1]. Nevertheless, since nomeasurement of baselineMPB
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Fig. 4 a, b, c, d, e, and f. Muscle
proteolysis signaling after the first
retraining session (20-h retrain)
and after 2 weeks of retraining (2-
week retrain). Data are expressed
relative to baseline levels and
presented as geometric means ±
back-transformed SE. Log-
transformed data were analyzed
with a two-way repeated measure
ANOVA. Interaction effect was
observed in f (p < 0.05), but no
significant differences from
subsequent post hoc testing were
seen. No group effects were
observed (p > 0.05), but time
effects appeared (p < 0.05). b
Denote significant different from
20-h retrain (p < 0.05). Tendency
(0.05 < p < 0.10) from ANOVA
testing is shown within the figure
in upper right panel
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was included in the present study, it is not possible to saywhether
the mean MPB during immobilization actually differed from a
normal free-living level.
Although it has been demonstrated that MPB increases in the
hours/days of recovery following acute resistance exercise [3,
30], it is largely unknown if the mean MPB is similarly affected
during longer periods of resistance training. In the present study,
a limited number of subjects had the MPB measured (n = 7 and
n = 6 in the Ibu and Plc groups, respectively), and therefore a risk
of a type II error should be considered. However, in the two-way
ANOVA test, the impact of NSAID appeared nonsignificant;
hence, the condition comparison (immobilization versus
retraining) becomes rather strong. Therefore, more power (N =
13) is present in that comparison, and the finding that the myo-
fibrillar breakdown rate was higher during 2 weeks of unaccus-
tomed rehabilitation resistance training compared to the immo-
bilization period (Fig. 2) is rather strong. It was expected that the
MPB would be higher during the retraining period compared to
the muscle unloading period, because of the skeletal muscle re-
modeling processes taking place during early periods of resis-
tance training [8, 9, 50]. Moreover, the present retraining period,
following a period of muscle inactivity, could be expected to
induce a more pronounced physiological impact than a 2-week
period of resistance training applied to normally active muscles,
due to the state of muscle atrophy combined with the abrupt and
unaccustomed training sessions.
In the following section, we will discuss the findings dur-
ing the immobilization and retraining periods, separately.
During immobilization, NSAID treatment did neither affect
the loss of muscle mass [11], the MPB (Fig. 2), nor degradation
signaling (Fig.3). These findings were in contrast to the study
hypothesis. Previously, a muscle-protective effect of NSAIDs
has been demonstrated in cancer patients and tumor-bearingmice
challenged by muscle catabolism [10, 24, 26]. However, the
muscle catabolism induced by cancer cachexia may likely differ
from the muscle atrophy induced by simple limb immobilization
in healthy, older humans. This may at least partly be due to
differences in systemic levels of catabolic drivers, such as
hypercortisolemia, hypercytokinemia, and insulin resistance that
may directly stimulate MPB [1, 34]. Thus, inflammation and
muscle degradation presumably plays a more prominent role in
cancer-induced cachexia [28, 43], and thus, the underlying
muscle-regulatory mechanisms and the effect of NSAIDs may
not be directly comparable between cancer patients and healthy
older individuals. Somehow in contrast though, dietary fish oil
supplementation appears to reduce muscle degradation after
10 days of immobilization even in healthy adult rats [51]. This
finding may be explained by the notion that muscle degradation
contribute substantially more to the immobilization-induced
muscle catabolism in rats than in humans [1, 32].
During retraining, the NSAID treatment did not significant-
ly affect the muscle regrowth in the present study [11].
Previously, both fish oil and NSAID treatment have been
shown to impair muscle recovery in rats andmice after periods
of muscle inactivity [6, 52], which was associated with a de-
creased level of muscle inflammation [6]. However, even
though muscle damage and infiltration of intramuscular in-
flammatory cells (e.g., macrophages or leucocytes) were not
measured in the present study, it has been shown that NSAIDs
do not influence the postexercise production of these inflam-
matory mediators in human muscle [29, 48]. Moreover, the
present resistance training rehabilitation protocol is not com-
parable to the “normal ambulatory activity” used for muscle
recovery in these animal studies [6, 52].
In the present study, protein expression of different signal-
ing molecules involved in muscle protein degradation and
inflammation was measured in both the cytosolic and nuclear
subcellular fractions (Figs. 3 and 4). The exploration of both
breakdown rates by tracer methodology and intramuscular
signaling allows a better understanding of the processes and
helps the interpretation of the obtained individual results. A
general observation was that NSAIDs did not affect the mea-
sured signaling molecules, which is in line with the finding
that the MPB rate was unaffected by NSAIDs.
Given that inactivity and bed rest have been shown to increase
systemic inflammation [7, 22], we hypothesized that NF-kB sig-
naling would increase after 2 weeks of immobilization and that
this response would be attenuated by NSAID treatment.
However, no changes in cytosolic or nuclear NF-kB p65 were
observed in any of the groups, suggesting that local inflammation
was not increased by the unilateral leg immobilization. The latter
was supported by unchanged IKB-alpha levels. In the absence of
an inflammatory response in the placebo group, it is not surpris-
ing that NF-kB signaling was unaffected by NSAID treatment.
However, we cannot exclude the possibility that an inflammatory
response occurred in the initial phase of the 2-week immobiliza-
tion period.
FoxO3 has been shown to regulate the two major systems
of protein breakdown in skeletal muscle, namely, the
ubiquitin-proteasome system and the autophagy-lysosomal
pathway, through transcription of genes such as MAFbx/
atrogin-1, MuRF1, LC3B, and BNIP3 [23, 39]. In a situation
of increased muscle protein breakdown, one might therefore
expect increased translocation of FoxO3a [17], reflected by
decreased cytosolic and increased nuclear levels. Indeed, cy-
tosolic FoxO3a was reduced following 2 weeks of immobili-
zation, but this did not coincide with increased nuclear levels
(no change). Accordingly, the cytosolic reduction likely rep-
resented attenuated de novo synthesis of FoxO3a. The latter is
supported by previous observations of reduced gene expres-
sion of FoxO3 following 4 days of immobilization in both
young and old men [40]. Although the present reduction in
cytosolic FoxO3a immediately after immobilization is some-
what in agreement with the lower myofibrillar breakdown rate
during immobilization than during retraining, it should be not-
ed that muscle protein signaling molecules only represent an
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instant picture of the muscle protein turnover rate at any given
time point, which opposites the measured mean MPB rate.
Therefore, the measured muscle protein signaling molecules
may not necessarily be tightly coupled to the actual muscle
protein turnover rate at a given time point.
Ubiquitination of cytosolic proteins, an estimate of the
amount of proteins marked for degradation [37], was un-
changed in both groups following immobilization.
Previously, increased ubiquitination has been observed after
2, but not 14 days of disuse in young individuals [15].
Regardless, results for ubiquitination should be interpreted
with care, considering that both the rate of protein
ubiquitination and the rate of proteasomal degradation deter-
mine the net amount of ubiquitinated proteins at any given
time point. Nevertheless, although it only represents an imme-
diate “snap shot,” the measurement of ubiquitinated protein
indicates that MPB was not increased from baseline levels
after the immobilization period in the present study.
In untrained individuals, resistance exercise causes an in-
flammatory response [47], as well as increased MPB rates
[31]. It has been shown previously that NSAIDs may inhibit
training induced increases in gene expression of IL-6 and
MuRF-1 in elderly [46]. Therefore, we investigated the effect
of NSAIDS on pro-inflammatory signaling and markers of
proteolysis in the early and late phase of retraining in the
present study. Protein levels of nuclear NF-kB p65 were
higher after the first, compared to the last retraining session,
and a similar tendency was observed in the cytosolic fraction.
This indicates a more pronounced inflammatory response ear-
ly in the retraining period, when subjects are unfamiliar to the
training stimulus. Nevertheless, no effect of NSAIDS was
observed, neither on NF-kB, IKB alpha, ubiquitination, nor
FoxO3a, in line with the observation that neither FBR nor
hypertrophy was affected by the ibuprofen treatment.
Conclusion
The present study measured the average skeletal muscle myo-
fibrillar breakdown rate in older individuals during daily life
periods of immobilization and subsequent rehabilitation train-
ing using the deuterated (2H2O) water–based methodology.
The myofibrillar breakdown was lower during immobilization
than during retraining but was not affected by NSAID treat-
ment in any of the periods. Moreover, the protein expression
of different signaling molecules related to myofibrillar degra-
dation in the cytosolic and nuclear subcellular fractions dif-
fered somewhat over the course of the intervention but was
likewise unaffected by NSAID treatment.
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